ATEA PHARMACEUTICALS INC's ticker is AVIR and the CUSIP is 04683R106. A total of 126 filers reported holding ATEA PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.50 and the average weighting 0.2%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $636,333 | -19.2% | 212,111 | +0.8% | 0.00% | – |
| Q2 2023 | $787,383 | +8.4% | 210,530 | -2.9% | 0.00% | – |
| Q1 2023 | $726,193 | +2.1% | 216,774 | +46.5% | 0.00% | – |
| Q4 2022 | $711,538 | +7.2% | 147,929 | +26.8% | 0.00% | – |
| Q3 2022 | $664,000 | -22.8% | 116,640 | -3.7% | 0.00% | – |
| Q2 2022 | $860,000 | +13.5% | 121,132 | +15.3% | 0.00% | – |
| Q1 2022 | $758,000 | +155.2% | 105,018 | +215.4% | 0.00% | – |
| Q4 2021 | $297,000 | -97.3% | 33,293 | -89.5% | 0.00% | -100.0% |
| Q3 2021 | $11,134,000 | +2279.1% | 317,579 | +1356.9% | 0.00% | – |
| Q2 2021 | $468,000 | -11.2% | 21,798 | +155.2% | 0.00% | – |
| Q1 2021 | $527,000 | – | 8,542 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tyrus Capital S.A.M. | 1,260,000 | $4,712,400 | 33.11% |
| BML Capital Management, LLC | 2,236,239 | $8,363,534 | 7.52% |
| TANG CAPITAL MANAGEMENT LLC | 3,026,455 | $11,318,942 | 1.67% |
| Stonepine Capital Management, LLC | 752,088 | $2,812,809 | 1.02% |
| Bain Capital Life Sciences Investors, LLC | 2,485,638 | $9,296,286 | 0.96% |
| CM Management, LLC | 250,000 | $935 | 0.91% |
| EcoR1 Capital, LLC | 6,995,861 | $26,164,520 | 0.64% |
| Cormorant Asset Management, LP | 1,547,181 | $5,786,457 | 0.32% |
| SECTORAL ASSET MANAGEMENT INC | 501,537 | $1,875,748 | 0.31% |
| Auour Investments LLC | 177,000 | $661,980 | 0.28% |